Device
Vivity IOL
Vivity IOL is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (50.0%)
N/A1 (50.0%)
Trials by Status
completed250%
terminated125%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_4
Symfony vs Vivity in Dim Light
NCT06229106
recruitingnot_applicable
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
NCT05624398
completed
Post-Market Study of Alcon Intraocular Lenses
NCT05414565
terminated
Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients
NCT05961046
Clinical Trials (4)
Showing 4 of 4 trials
NCT06229106Phase 4
Symfony vs Vivity in Dim Light
NCT05624398Not Applicable
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
NCT05414565
Post-Market Study of Alcon Intraocular Lenses
NCT05961046
Visual Performance of the Vivity IOL in Post-myopic LASIK and PRK Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4